Genetic associations of the visfatin G-948T polymorphism with obesity-related metabolic traits in an Iranian population

被引:5
作者
Javanmard, Shaghayegh Haghjooy [1 ]
Dehghananzadeh, Raheleh [1 ]
Rafiee, Laleh [1 ]
Naji, Hajar [1 ]
Rezayat, Azadeh [1 ]
Sarrafzadegan, Nizal [2 ]
机构
[1] Isfahan Univ Med Sci, Isfahan Cardiovasc Res Inst, Appl Physiol Res Ctr, Hezarjerib St, Esfahan, Iran
[2] Isfahan Univ Med Sci, Isfahan Cardiovasc Res Inst, Isfahan Cardiovasc Res Ctr, Esfahan, Iran
来源
JOURNAL OF RESEARCH IN MEDICAL SCIENCES | 2016年 / 21卷
关键词
G-948T; Iran; lipoprotein; obesity; polymorphism; visfatin; TYPE-2; DIABETES-MELLITUS; COLONY-ENHANCING FACTOR; PLASMA VISFATIN; FAT; INFLAMMATION; CHOLESTEROL; PBEF1; RISK;
D O I
10.4103/1735-1995.193177
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Obesity is a global public health problem. Visfatin, as an adipocytokine, is coded by a gene known as nicotinamide phosphoribosyltransferase. So far, results were conflicted regarding correlations of visfatin with obesity and metabolic variables. he present study aimed to explore the association between G-948T polymorphism of visfatin gene with obesity and lipid profile in a nationally representative sample of Iranian population. Materials and Methods: In this case-control study, we assessed 129 randomly selected patients with obesity and 182 healthy normal weight controls from participants of Isfahan Healthy Heart Program. Genomic DNA was isolated from peripheral blood cells, and high-resolution melt polymerase chain reaction was performed to explore the presence of G-948T polymorphism. Results: T carriers "GT + TT" were statistically more frequent in the obese patients than the controls (P = 0.013; odds ratio = 1.9, 95% confidence interval = 1.1-3.1). he serum levels of total cholesterol and low-density lipoprotein cholesterol (LDL-C) were significantly different between T carriers and GG homozygote genotype (P = 0.03 and 0.02, respectively). Conclusion: We concluded that visfatin G-948T polymorphism was correlated with obesity, total cholesterol, and LDL-C levels in our population.
引用
收藏
页数:5
相关论文
共 30 条
  • [1] The effects of NAMPT haplotypes and metabolic risk factors on circulating visfatin/NAMPT levels in childhood obesity
    Belo, V. A.
    Luizon, M. R.
    Lacchini, R.
    Miranda, J. A.
    Lanna, C. M. M.
    Souza-Costa, D. C.
    Tanus-Santos, J. E.
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2015, 39 (01) : 130 - 135
  • [2] Plasma visfatin concentrations and fat depot-specific mRNA expression in humans
    Berndt, J
    Klöting, N
    Kralisch, S
    Kovacs, P
    Fasshauer, M
    Schön, MR
    Stumvoll, M
    Blüher, M
    [J]. DIABETES, 2005, 54 (10) : 2911 - 2916
  • [3] Nicotinamide Phosphoribosyltransferase/Pre-B-Cell Colony Enhancing Factor/Visfatin Plasma Levels and Clinical Outcome in Patients With Dilated Cardiomyopathy
    Bobbert, Peter
    Kuehl, Uwe
    Poller, Wolfgang
    Rauch, Ursula
    Schultheiss, Heinz-Peter
    Skurk, Carsten
    [J]. JOURNAL OF CARDIAC FAILURE, 2015, 21 (04) : 330 - 338
  • [4] Genetic variation in the visfatin gene (PBEF1) and its relation to glucose metabolism and fat-depot-specific messenger ribonucleic acid expression in humans
    Boettcher, Yvonne
    Teupser, Daniel
    Enigk, Beate
    Berndt, Janin
    Kloeting, Nora
    Schoen, Michael R.
    Thiery, Joachim
    Blueher, Matthias
    Stumvoll, Michael
    Kovacs, Peter
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (07) : 2725 - 2731
  • [5] The relationship of visfatin/pre-B-cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation, insulin resistance, and plasma lipids
    Chang, Yi-Cheng
    Chang, Tien-Jyun
    Lee, Wei-Jei
    Chuang, Lee-Ming
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2010, 59 (01): : 93 - 99
  • [6] Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus
    Chen, MP
    Chung, FM
    Chang, DM
    Tsai, JCR
    Huang, HF
    Shin, SJ
    Lee, YJ
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (01) : 295 - 299
  • [7] Macrophages in human visceral adipose tissue:: increased accumulation in obesity and a source of resistin and visfatin
    Curat, CA
    Wegner, V
    Sengenès, C
    Miranville, A
    Tonus, C
    Busse, R
    Bouloumié, A
    [J]. DIABETOLOGIA, 2006, 49 (04) : 744 - 747
  • [8] Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance
    Dogru, Teoman
    Sonmez, Alper
    Tasci, Ilker
    Bozoglu, Ergun
    Yilmaz, Mahmut Ilker
    Genc, Halil
    Erdem, Gokhan
    Gok, Mahmut
    Bingol, Necati
    Kilic, Selim
    Ozgurtas, Taner
    Bingol, Sezin
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 76 (01) : 24 - 29
  • [9] Serum visfatin is associated with type 2 diabetes mellitus independent of insulin resistance and obesity
    Esteghamati, Alireza
    Alamdari, Azam
    Zandieh, Ali
    Elahi, Seerat
    Khalilzadeh, Omid
    Nakhjavani, Manouchehr
    Meysamie, Alipasha
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 91 (02) : 154 - 158
  • [10] RETRACTED: Visfatin: A protein secreted by visceral fat that mimics the effects of insulin (Retracted article, see vol 318, pg 565, 2007)
    Fukuhara, A
    Matsuda, M
    Nishizawa, M
    Segawa, K
    Tanaka, M
    Kishimoto, K
    Matsuki, Y
    Murakami, M
    Ichisaka, T
    Murakami, H
    Watanabe, E
    Takagi, T
    Akiyoshi, M
    Ohtsubo, T
    Kihara, S
    Yamashita, S
    Makishima, M
    Funahashi, T
    Yamanaka, S
    Hiramatsu, R
    Matsuzawa, Y
    Shimomura, I
    [J]. SCIENCE, 2005, 307 (5708) : 426 - 430